Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Wave Two: The SURPASS Diabetes Program The SURPASS trials evaluated tirzepatide in adults with type 2 diabetes, using glycemic control (change in HbA1c) as the primary endpoint and body-weight change among secondary endpoints
Not approved for human or animal use
Most states Boards of Pharmacy uphold and ensure these standards
If headaches persist beyond two weeks without improvement or worsen over time, discussing adjustment options with your provider becomes important
Whether you are on your first week or six months into treatment, the nutrition principles here apply
By effectively addressing obesity-linked OSA for many (it reversed the condition in up to 50.2% of SURMOUNT-OSA trial participants), GLP-1s prescribed by primary care physicians and other specialists are clearing the decks, allowing sleep specialists to refocus on the patients whose condition is driven by other factors
US$ 20.63
US$ 21.38
US$ 25.54
US$ 25.79
US$ 22.24
US$ 29.65
US$ 25.73
US$ 26.42
US$ 27.25
